跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial
Approved
STANDARD
PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
df499d613f687c7b
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
df499d613f687c7b
Product Name
PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial
Artg Id
163897
Artg Name
PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2009-09-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3da7dae6d7f41292f84c07156c366083.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/55420b825e5d154fa632560909240961.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
df499d613f687c7b
Type
Standard
Back to TGA Approvals